Kisqali 600 MG daily dose 63S
Ended Awarded Last action
- Contract number
- SPE2DR26F9DF2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $66,033
Award facts
- Contract value 100% obligated
- $66,032.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $66,032.52 firm fixed price delivery order to AmerisourceBergen Drug Corp for Kisqali 600 mg daily dose tablets (quantity 63) on November 25, 2025, with completion targeted for December 17, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026 that enables global pharmaceutical and medical supply support for military healthcare programs.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This specific delivery order for Kisqali, a cancer treatment medication, represents routine pharmaceutical fulfillment under the company's comprehensive global pharmaceutical support vehicle. The DLA Troop Support is planning successor Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen as a key incumbent vendor in federal military healthcare pharmaceutical procurement.
Quick answers
Who was awarded contract SPE2DR26F9DF2?
SPE2DR26F9DF2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F9DF2 worth?
The government has obligated $66,033 on SPE2DR26F9DF2.
Is contract SPE2DR26F9DF2 an order under another contract?
Yes. SPE2DR26F9DF2 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9DF2 competed?
The extent of competition for SPE2DR26F9DF2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award